News Lilly loses bid to nix $184m Medicaid fraud penalty Lilly has lost an appeal in a whistleblower lawsuit that alleged it had defrauded Medicaid by underpaying rebates.
News Court sides with Vanda over FDA's Hetlioz rejection A court has ordered the FDA to revisit a decision to turn down a drug for jet lag developed by Vanda, potentially setting a crucial legal precedent.
News Texas suit claims Lilly bribed providers to prescribe drugs Eli Lilly has been accused of giving illegal inducements to encourage medical providers in Texas to prescribe its medicines.
News GSK and CureVac settle mRNA patent spat with Pfizer/BioNTech BioNTech's takeover of CureVac seems to have unlocked a resolution to some of the patent litigation swirling around mRNA vaccine technologies.
News Meta harvested health data to target ads, jury concludes A jury in the US found that Meta illegally invaded the privacy of users of a health app, with implications for how tech firms handle personal data.
News HHS layoffs are finalised as thousands of pink slips arrive Federal staffers voice their anger and disgust as thousands of the Trump administration's reduction-in-force job losses are finalised.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
